Uber plans to deploy 20,000 robotaxis through a 300 million dollar deal with Lucid and Nuro, ramping up competition in the autonomous vehicle market.
Ultragenyx shares fell 34% after the FDA rejected its gene therapy for Sanfilippo syndrome due to manufacturing concerns.
Albertsons beats revenue and profit targets but shares slide as investors express concern over narrowing gross margins in the current retail climate.
Kraft Heinz is spinning off its 20 billion dollar grocery unit after years of declining sales and market value struggles.
US power companies are hiking rates by $29B as AI data centers strain the grid. Investors remain bullish on utilities despite consumer cost concerns.
